TribLIVE

| Business

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

3 more companies distance themselves from Deen

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

TGT $68.79 -$0.33

at close on THURSDAY

By The Associated Press
Friday, June 28, 2013, 12:01 a.m.
 

Paula Deen's merchandise and media empire is fast unraveling.

Retailers Target Corp. and Home Depot Inc. and diabetes drug maker Novo Nordisk became the latest companies to sever ties or distance themselves from the celebrity chef as fallout builds from revelations that she used racial slurs in the past.

Target, based in Minneapolis, said Thursday that it will phase out its Paula Deen-branded cookware and other items, which were sold on its website and in its stores.

Home Depot, which sold Paula Deen-branded cookware and kitchen products online, said it pulled the products off its website on Wednesday.

Diabetes drug maker Novo Nordisk said Thursday it and Deen have “mutually agreed to suspend our patient education activities for now.”

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Business Headlines

  1. Groups appeal Shell air permit for Beaver County project
  2. Private schools fill void in driver education in Western Pennsylvania
  3. Operating loss mounts at Highmark’s core hospital system
  4. AmEx’s accord with merchants over fees rejected by judge
  5. Esmark CEO Bouchard: Steel industry ‘weathered through the storm’
  6. Delphi buys CMU spinoff that makes self-driving car software
  7. Muni bond funds stressed
  8. Vote set at SEC to reveal pay gap between CEO and median employee at publicly traded companies
  9. Earnings misses by Allstate, NRG drag market lower for 3rd consecutive day
  10. Polymer Enterprises finds success in specialty tire market
  11. Israel’s Teva drops bid for Mylan, buys Allergan for $40.5B